Antibiotic resistance to kill millions in coming decades

Scientist holding a petri dish with pink agar
Photo: Arpon Pongkasetkam / Shutterstock

Drug-resistant infections already kill more than a million people a year, and new global health forecasts say that toll could nearly double by 2050 unless doctors and governments change course now.

Story Snapshot

  • A 2019 United Nations-linked report warned drug-resistant diseases could cause 10 million deaths a year by 2050 without action.
  • A later global study found 1.27 million deaths were directly caused by antibiotic-resistant bacteria in 2019 alone, with nearly 5 million more linked to it.
  • Updated 2024 forecasts project 1.91 million deaths directly tied to resistance and 8.22 million associated deaths by 2050.
  • Researchers say better hospital hygiene, smarter prescribing, and new drug incentives could prevent millions of these deaths.

Decades of Warnings About a Growing Threat

Antimicrobial resistance happens when bacteria evolve to survive the drugs meant to kill them. In 2019, the United Nations Ad hoc Interagency Coordinating Group on Antimicrobial Resistance released a stark warning. It said drug-resistant diseases could cause 10 million deaths every year by 2050 if the world failed to act, with economic damage comparable to the 2008 financial crisis.

That warning helped push governments and health agencies to take the threat seriously. It became one of the most repeated statistics in global health policy, cited by the World Health Organization and national health agencies pressing for faster action on new treatments and tighter prescribing rules.

Newer Forecasts Offer a More Precise, Still Grim Picture

A major 2022 study in The Lancet gave researchers their first detailed count of the actual damage. It found that in 2019, 1.27 million deaths were directly caused by antibiotic-resistant bacterial infections. Another 4.95 million deaths that year were linked to resistant infections, even if resistance was not the sole cause.

A follow-up Lancet analysis using updated data through 2021 refined the long-term outlook. Researchers now forecast 1.91 million deaths directly attributable to resistance and 8.22 million associated deaths worldwide in 2050. The numbers are lower than the original 10 million estimate, but they still describe a mounting crisis that kills more people each year than malaria and HIV combined in some projections.

Why Common Infections Are Becoming Harder to Treat

Resistance spreads when antibiotics are overused or misused in people, animals, and farming. Bacteria that survive a dose multiply and pass resistance traits to new generations. Infections once treated easily, like urinary tract infections, pneumonia, and bloodstream infections, now sometimes fail to respond to standard drugs, forcing doctors to use stronger, more toxic, and more expensive backup treatments.

The World Health Organization’s Bacterial Priority Pathogens List says the stakes go beyond lives lost. Researchers estimate that investing in better health care quality and rolling out new antibiotics fairly could prevent up to 92 million resistance-related deaths by 2050. That gap between what is possible and what is happening reflects years of underinvestment in new antibiotic development.

The Push for New Drugs and Smarter Prescribing

Part of the problem is economic. Antibiotics are less profitable than other medicines because they are taken for short periods and doctors are told to use them sparingly to slow resistance. That discourages drug companies from investing in new ones, leaving fewer tools in reserve as old drugs stop working.

Public health researchers say prevention does not require miracle cures. An Organisation for Economic Co-operation and Development analysis found that stewardship programs, better hand hygiene, and improved sanitation in hospitals could add between 71,000 and 153,000 life years annually across wealthy nations, often at low cost.

Countries that have banned over-the-counter antibiotic sales and tightened prescribing rules have already seen measurable drops in misuse among children with respiratory infections. Health officials argue these are proof that national policy choices, not just new drugs, can slow the spread of resistance before it reaches the deadlier scenarios researchers have mapped out for 2050.

Sources:

youtube.com, thelancet.com, who.int, link.springer.com, oecd.org, pmc.ncbi.nlm.nih.gov